Literature DB >> 22548815

Right ventricular dysfunction in chronic lung disease.

Todd M Kolb1, Paul M Hassoun.   

Abstract

Right ventricular (RV) dysfunction arises in chronic lung disease when chronic hypoxemia and disruption of pulmonary vascular beds increase ventricular afterload. RV dysfunction is defined by hypertrophy with preserved myocardial contractility and cardiac output. RV hypertrophy seems to be a common complication of chronic and advanced lung disease. RV failure is rare, except during acute exacerbations of chronic lung disease or when multiple comorbidities are present. Treatment is targeted at correcting hypoxia and improving pulmonary gas exchange and mechanics. There are no data supporting the use of pulmonary hypertension-specific therapies for patients with RV dysfunction secondary to chronic lung disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548815      PMCID: PMC3342531          DOI: 10.1016/j.ccl.2012.03.005

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  115 in total

1.  A clinicopathological study of fatal chronic airways obstruction.

Authors:  K W Scott
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

2.  Effect of intrathoracic pressure on left ventricular performance.

Authors:  A J Buda; M R Pinsky; N B Ingels; G T Daughters; E B Stinson; E L Alderman
Journal:  N Engl J Med       Date:  1979-08-30       Impact factor: 91.245

3.  Predicting mortality in patients with sarcoidosis awaiting lung transplantation.

Authors:  Andrew F Shorr; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

4.  Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

Authors:  Hanno H Leuchte; Claus Neurohr; Rainer Baumgartner; Michael Holzapfel; Wolfgang Giehrl; Michael Vogeser; Jürgen Behr
Journal:  Am J Respir Crit Care Med       Date:  2004-04-15       Impact factor: 21.405

5.  Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party.

Authors: 
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

6.  Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; C Hirth; A Ducolone; R Mirhom; J Rasaholinjanahary; M Ehrhart
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

7.  Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome.

Authors:  T D Bradley; R Rutherford; R F Grossman; F Lue; N Zamel; H Moldofsky; E A Phillipson
Journal:  Am Rev Respir Dis       Date:  1985-06

8.  Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.

Authors:  R Naeije; C Mélot; P Mols; R Hallemans
Journal:  Am Rev Respir Dis       Date:  1982-01

9.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease.

Authors:  R M Timms; F U Khaja; G W Williams
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

10.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

View more
  14 in total

Review 1.  State of the Art Review of the Right Ventricle in COPD Patients: It is Time to Look Closer.

Authors:  Daniela Graner Schuwartz Tannus-Silva; Marcelo Fouad Rabahi
Journal:  Lung       Date:  2016-12-03       Impact factor: 2.584

2.  Accelerated right heart failure due to lung resection in the setting of chronic respiratory failure.

Authors:  Naji Maaliki; Jorge Verdecia; Madeline Fasen; Aleem Azal Ali; Win Aung
Journal:  J Cardiol Cases       Date:  2021-07-08

Review 3.  Group 3 Pulmonary Hypertension: From Bench to Bedside.

Authors:  Navneet Singh; Peter Dorfmüller; Oksana A Shlobin; Corey E Ventetuolo
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

4.  Relationship of Right Ventricular Size and Function with Respiratory Status in Duchenne Muscular Dystrophy.

Authors:  Muddassir Mehmood; Stephanie A Ambach; Michael D Taylor; John L Jefferies; Subha V Raman; Robin J Taylor; Hemant Sawani; Jacob Mathew; Wojciech Mazur; Kan N Hor; Hussein R Al-Khalidi
Journal:  Pediatr Cardiol       Date:  2016-03-02       Impact factor: 1.655

Review 5.  RV diastolic dysfunction: time to re-evaluate its importance in heart failure.

Authors:  Richard G Axell; Stephen P Hoole; James Hampton-Till; Paul A White
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

6.  Echocardiographic characteristics of patients with antisynthetase syndrome.

Authors:  Jaimie L Bryan; Ralph Matar; Abheek Raviprasad; Veronica Kuteyeva; Eduardo Milla; Omkar Begateri; Divya Patel; Diana G Manjarres; Saminder S Kalra; Jeffrey Robinson; Akram Khan; Raju Reddy
Journal:  Pulm Circ       Date:  2022-04-27       Impact factor: 2.886

7.  Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy.

Authors:  Aurelija Abraityte; Ida G Lunde; Erik T Askevold; Annika E Michelsen; Geir Christensen; Pål Aukrust; Arne Yndestad; Arnt Fiane; Arne Andreassen; Svend Aakhus; Christen P Dahl; Lars Gullestad; Kaspar Broch; Thor Ueland
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

Review 8.  Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.

Authors:  Scott D Collum; Javier Amione-Guerra; Ana S Cruz-Solbes; Amara DiFrancesco; Adriana M Hernandez; Ankit Hanmandlu; Keith Youker; Ashrith Guha; Harry Karmouty-Quintana
Journal:  Can Respir J       Date:  2017-02-13       Impact factor: 2.409

Review 9.  Pulmonary hypertension and right heart dysfunction in chronic lung disease.

Authors:  Amirmasoud Zangiabadi; Carmine G De Pasquale; Dimitar Sajkov
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

10.  Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease.

Authors:  Chun-Rong Ju; Miao Chen; Jian-Heng Zhang; Zhi-Ya Lin; Rong-Chang Chen
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.